Abstract: Novel enantiopure pseudopeptide models containing a central -(-lactam)-(Aa)-scaffold characterized by the combined presence of an -alkyl--amino--lactam (i+1) residue and a -substituted (i + 2) amino acid have been readily synthesized from -alkyl serines. The conformational analysis of such -lactam pseudopeptides conducted in CDCl3 and DMSO-d6 solutions using 1D-and 2D-NMR techniques revealed an equilibrium between -II turn and -turn conformers, which was ultimately modulated by the relative configuration of the -(-lactam)-(Aa)-residues. Long-range chiral effects on the -lactam pseudopeptide conformers were also found when two (i) and (i + 3) chiral residues were attached to the termini of a central -(-lactam)-(Aib)-segment. In such mimetics, heterochiral (i) and (i + 3) residues reinforced a -II turn conformer, whereas homochiral corner residues stabilized an overlapped -II/ -I double turn motif. No -hairpin nucleation was observed in any instance. In good agreement with the conformers found in solution, -turned and open structures were also characterized by X-ray crystallography. Relative stabilities of the different conformers were estimated computationally at a B3LYP/6-31++G** calculation level, and finally, a conformation equilibrium model based on steric inter-residual interactions around the -(-lactam)-(i + 2)-segment was proposed to account for the observed chiral effects. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 2 substituted (i+2) amino acid have been readily synthesized from α-alkyl serines. The conformational analysis of such β-lactam pseudopeptides conducted in CDCl 3 and DMSO d6 solutions using 1D and 2D-NMR techniques revealed an equilibrium between β-II turn and γ-turn conformers, which was ultimately modulated by the relative configuration of the -(β-lactam)-(Aa)-residues. Long range chiral effects on the α-lactam pseudopeptide conformers were also found when two (i) and (i+3) chiral residues were attached to the termini of a central -(β-lactam)-(Aib)-segment. In such mimetics, heterochiral (i) and (i+3) residues reinforced a β-II turn conformer, whereas homochiral corner residues stabilized an overlapped β-II/ β-I double turn motif. No β-hairpin nucleation was observed in any instance. In good agreement with the conformers found in solution, β-turned and open structures were also characterized by X-ray crystallography. Relative stabilities of the different conformers were estimated computationally at a B3LYP/6-31++G** calculation level and, finally, a conformation equilibrium model based on steric inter-residual interactions around the -(β-lactam)-(i+2)-segment was proposed to account for the observed chiral effects.
Introduction
Chirality is at the origin of the regular folding patterns occurring in proteins and natural peptides. It is well known that short "all-L" peptides may experience dramatic changes in their backbone conformation due to the replacement of a single residue by an achiral unit or a D-configuration amino acid. 1 This phenomenon was first found in natural peptides and is now widely used as a strategy to design peptidomimetics stabilizing reverse turn motifs such as β-turns 2 1 and γ-turns 3 2 (Figure 1 , top).
3 bridges within contiguous CαH and NH positions (Freidinger lactams) 5 are embedded in the native peptide backbone (Figure 1 , bottom). Formation of more complex structures, such as the doubly hydrogen-bonded β-hairpins 3 (antiparallel β-sheet nucleators) is also strongly dependent on the configurations of the terminal residues (i) and (i+3). Unfortunately, most of the (i+1)-(i+2) dipeptide lactam surrogates used routinely as turn mimetics 7 possess comparatively large external fragments and their restraint elements (cycles) and recognition groups (R 1 and R 2 ) are often crammed in the scaffold. 8 Alternatively, the studies carried out on proline peptides 9 were only of limited success, because of their inherent ring-puckering. This makes it very difficult to interpret the stereoelectronic interactions arising from the chirality effect of residues neighboring the lactam moiety. Hence, a scaffold size reduction strategy intended to design "minimal"
short peptide models becomes particularly attractive in terms of design simplicity and folding interpretation.
In our first accomplishment in this area 10 we introduced the β-lactam peptides 4 containing a central
Results and Discussion
Design and Synthesis of β-Lactam Pseudopeptide Models. Short pseudopeptide models 5-7
( Figure 2 ) with homogeneous (R) configuration at the Cα stereocenter of the β-lactam ring were selected for development because they are reminiscent of constrained natural L α-amino acid residues. 16 Configurationally related β-lactam peptides 5 and 6 containing a single additional stereocenter at residue (i+2) were designed to carry terminal groups with different steric demands. Accordingly, mimetics 5 [Ac-(α-Me-β-Lactam)-Aa-Me] represented the smallest capped β-lactam dipeptide structures containing three peripheral methyl groups, whereas mimetics 6 [Boc-(α-Bn-β-Lactam)-AaAib-OH] had a larger central benzyl group and bulkier achiral N-and C-terminal groups (Boc and Aib-OH) . Finally, pseudopeptides 7 [Boc-Ala*-(α-Bn-β-Lactam)-Aib-Ala*-NH 2 ] were designed to ascertain the chiral effect of two additional stereocenters at the (i) and (i+3) alanine residues on the possible β-hairpin nucleation. 
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Figure 2. Top: β-Lactam pseudopeptide models 5-7 selected to study the chiral effect of residues (i), (i+2) and (i+3) on the peptide folding. Bottom: Synthesis of the β-lactam dipeptide scaffolds 8-9.
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The enantiopure scaffolds 8-9 required to form the central -(i+1)-(i+2)-pseudopeptide segments were easily obtainable from the corresponding α-alkylserinates 17 10-11 according to an operatively very simple method developed in our laboratory. 18 Tables 1 and 2 collect the details of the transformation of the dipeptide scaffolds 8, 9 and 14 into the target β-lactam pseudopeptide models.
As shown in Table 1 , the synthesis of pseudopeptides 5 and 6 required the coupling of the C-terminal carboxylic acid group in 8 and 9 with methylamine and α-aminoisobutiric benzyl ester, respectively.
Formation of N-methylamides 12a-e from non-hindered β-lactam carboxylic acid precursors was best performed using the mixed anhydride method assisted by isobutyl chloroformate and Nmethylmorpholine, whereas couplings involving hindered Aib residues were most efficiently accomplished with EEDQ 19 reagent (products 13, 15, 16 and 7a-d). Denosylation of compounds 12-13
proceeded smoothly with thiophenol 20 in the presence of potassium carbonate to afford the intermediate α-amino-β-lactams, which were trapped in situ with acetic anhydride or di-tert-butyl dicarbonate to provide the desired mimetic models 5 or the analogs 6 after hydrogenolytic deprotection of the Cterminal benzyl ester. Stereochemical integrity was maintained in all transformations and no epimerization of the α' stereocenter could be detected via NMR and HPLC analysis of the reaction crudes. Following a similar protocol (Table 2) , mimetics 7 were obtained in good overall yields from the α',α'-dimethyl-β-lactam 14 after consecutive coupling with N-protected alanines 17 and alaninamides 18 using, respectively, the EEDQ and HATU/HOAT 21 reagents. 92 a) EEDQ reagent was used as the amide formation reagent.
b) The product was prepared from acid Boc-(β-Lactam)-Aib-OH, which was coupled to H-Aib-OBn and submitted to hydrogenolysis. destabilizing effects exerted by the chiral Aa residues on the conformer equilibrium. Although water was considered first as the most biologically meaningful medium for the study, finally DMSO d6 solvent was chosen for practical reasons to ensure solubility. In the case of peptides 5a-f, however, the recurrent overlapping of NH amide signals in dimethylsulfoxide precluded a straightforward interpretation of the results and CDCl 3 was used as solvent.
Solutions of each peptide 5a-f and 6a-f (5 x 10 -3 M) yielded sharp, well-resolved 1 H-NMR spectra consisting of single sets of signals in both solvents. All protons were unambiguously assigned from DQF-COSY and HMBC spectra (Supporting information Figures S1-S10). Chemical shift variations upon solvent change and 1 H-NMR thermal coefficients 22 for the exchangeable amide protons of the pseudopeptides in DMSO d6 solutions were determined over a temperature range of 300-325K at 5K intervals (Table 3 ). An inspection of the data recorded immediately revealed a totally different deshielding for the β-lactam N 2 H amide protons and the N 7 H protons of the (i+3) residue, suggesting the formation of a turned conformer in most of the cases with the N 7 H amide protons participating in the intramolecular hydrogen bond network of the β-lactam peptides and the N 2 H protons exposed to the solvent. This was evident from the analysis of thermal coefficients in DMSO d6 (see Table 3 , two right hand columns) showing absolute values in the range -2.3 to -4.9 ppb/K for N 7 H protons, whereas amides and carbamates N 2 H gave larger thermal coefficients (up to -8.9 ppb/K). Consistently, the solvent change from nonacceptor CDCl 3 to acceptor DMSO d6 resulted in a very small chemical shift variation for N 7 H amides in all peptides (0.1 -1.1 ppm), but in a significantly larger downfield shift (2.3 -2.8 ppm) in N 2 H β-lactam amides. While seeking more insight into the conformational differences between the β-lactam peptide diastereomers with (i+2) chiral α-amino acid residues (Table 3 , entries 2-9 5 and 8-11), we noticed that the thermal coefficients of the N 7 H protons where routinely larger for (i+2)-(S) diastereomers (5c, 5e and 6c, 6e) than for (i+2)-(R) ones (5b, 5d and 6b, 6d) and, furthermore, this effect was appreciably enhanced in pseudopeptides containing the bulkier phenylglycine residues (compare entries 4-5 and 10-11) . This lower exposure of the (R) diastereomers to the DMSO d6 coordinating solvent was consistent with the tight intramolecular N 7 H…O=C hydrogen bonding of β-turned β-lactam peptides 4 ( Figure 1 ), whereas the weaker hydrogen bonds of the (S) diastereomers (entries 3, 5, 9 and 11) suggested a partial folding of the peptide backbone into γ-turned conformers or open conformers possessing more exposed amide protons. Finally, the β-lactam pseudopeptides with nonchiral Gly or Aib (i+2) residues (entries 1, 6, 7 and 12) exhibited only very shielded N 7 H protons in DMSO d6 , consistent with their likely participation in stable β-turns. Tables S1 and S2 ; Figures S15 and S16).
Some expansions of the NOESY spectra of 5d-e (in CDCl 3 ) and 6d-e (in DMSO d6 ), incorporating a chiral phenylglycine (i+2) residue, are shown in Figure 3 as an example. The spectra gave rise to a number of NOE contacts, including the excellent diagnostic correlation peaks provided by the pro-R and pro-S diastereotopic C 4 protons placed, respectively, at the upper and lower faces of the β-lactam ring, as depicted in the figure. Only the 4H R proton gave a characteristic strong NOE contact (cross-peak a)
with the 3Me singlet in peptides 5 and with the benzylic moiety 3/3Ar in peptides 6. Conversely, the 4H S proton oriented to the lower face of the azetidin-2-one ring plane was used to monitor the 4H S -N 7 H distances (cross-peak b) and to estimate the preferred formation of canonical β-II turns (≈ 2.5-2.8Å), oriented toward the top side of the azetidinone ring was ruled out (see empty boxes in Figure 3 ).
From the inter-proton distances collected in Figure 3 , a regular chiral effect trend could be observed for the β-turn/γ-turn equilibrium as the α'-(R) configuration of peptides 5d/6d changed to α'-(S) in their diastereomers 5e/6e. Indeed, the average 4H S -N 7 H distances (cross-peak b) were significantly shorter for 5d and 6d (2.6 and 3.0 Å) than for their respective isomers 5e and 6e (3.8Å and >4 Å), suggesting that in the latter cases β-turns were weakened or broken in favor of γ-turns. This assumption was further supported by the close distances of the CαH 5 protons of the (S)-phenylglycine residue to 4H R and 4H S in 5e/6e and also by the absence of a comparable interaction for CαH 6 in 5d/6d. In line with these observations, β-lactam pseudopeptides 5b/6b and 5c/6c derived, respectively from (R)-alanine and (S)-alanine, showed similar β-turn destabilization trends upon (i+2) α' stereocenter configuration inversion, albeit in these cases the chiral effect was less pronounced (Supporting information, Figures S15 and   S16 ). Finally, all the β-lactam pseudopeptides with achiral (i+2) residues of glycine (5a/6a) or α-aminoisobutiric acid Aib (5f/6f) populated exclusively very stable β-turn conformations and showed no tendency to form γ-turns.
Solution Conformation of β-Lactam Peptides 7 with Chiral (i) and (i+3) Residues. Following the same NMR methodology disclosed above, we next studied the conformational behavior of β-lactam peptidomimetics 7a-d in DMSO d6 to check the chiral effect of (i) and (i+3) alanine residues on the nucleation of β-sheets. The thermal coefficient data collected in Table 4 show that all the (i+3) N 8 H amide protons participate in strong intramolecular hydrogen bonds, likely forming stable β-II turns.
Interestingly, unlike the "heterochiral" diastereomers 7b and 7d, each "homochiral" diastereomer 
.5 a Thermal coefficients in ppb/K measured in DMSO d6 . 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 7a (R,R) and 7c (S,S) showed an additional solvent-shielded N 10 H terminal trans-amide proton, which we hoped would participate as donors of the Boc group in β-hairpin type secondary structures. A more detailed examination of the inter-proton distances from ROESY spectra of 7a, however, revealed that the actual acceptor of the N 10 H amide proton was the β-lactam carbonyl oxygen, thus forming two overlapped β-II/β-I turns ( Figure 4 ). In particular, this assumption was further supported by the long range N 8 H-N 10 H NOE diagnostic cross-peak h observed for the homochiral peptide 7a, but not for the heterochiral peptide 7b (for an analogous behavior for diastereomers 7c/7d see Supporting information Figure S17 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Solid State Conformation of β-Lactam Peptidomimetics 5-7. Single crystals of the β-lactam pseudopeptides 5e, 5f, 7a and 7d were grown from their solutions in MeOH and were used for lowtemperature X-ray structure determination ( Figure 5 ). A detailed analysis of some key structural parameters, Table 5 , revealed the formation of well defined β-II turn conformers in all instances, with the exception of the (S)-phenylglycine-derived mimetic 5e, which showed an extended backbone structure with the (i) acetamido group and the (i+3) phenylglycine N-methylcarbamoyl group lying on opposite sides of the plane of the β-lactam ring. Consistent with the extremely destabilized γ-turn conformation observed for this pseudopeptide in solution by NMR, no intramolecular hydrogen bond was detected in the solid state. Instead, each NH amide group acted as a donor to form intermolecular bifurcated hydrogen bonds with the C=O oxygen atom of the β-lactam ring.
Mimetic models 5f, 7a and 7d containing the (i+2) Aib residue fulfilled all the structural criteria of canonical type-II β-turns in terms of (i) 
angles (159º-167º) and the δ pseudodihedral angle formed by the four Cα atoms (5º-14º), which was very close to the ideal null value. Only a slight distortion (15-20º) caused by the coplanar arrangement of N (i+1) , Cα (i+1) , N (i+2) and Cα (i+2) atoms around the central β-lactam ring, was observed for the torsion angles φ -ψ in residues (i+1)-(i+2) with respect to the ideal values for a type-II β-turn. On the other hand, none of the peptides 7a and 7d showed a second hydrogen bond between the terminal Boc and NH 2 groups denoting the formation of β-sheet structures. In spite of that, the NH trans terminal amide proton of peptide 7a acted as a donor to the β-lactam carbonyl oxygen atom to form a quasycanonical β-I turn partially overlapping the β-II turn. To the best of our knowledge, this is the first example of such a type of double motif in solid pseudopeptide structures. Figure 5. ORTEP plots (50% probability ellipsoids) of the molecular structures of β-lactam peptidomimetics 5e, 5f, 7a and 7d in the solid state. Compound 7a shows overlapping β-II/β-I turns. Table 5 . Selected Geometric Parameters for β-Lactam Peptidomimetic Models 5e, 5f, 7a and 7d. groups with the carbonyl and methylene groups of the β-lactam ring (i+1). Accordingly, we submitted structures 5a-f to a DFT computational optimization 25 consisting of a Monte Carlo search (6-31G*), followed by structure minimization at the B3LYP/6-31++G** level. 26 Energy values collected in Figure   6 show a general trend for the preferred stabilization (2-3 Kcal/mol) of type II β−turns, over the normal γ-turns. As expected, no type-I β−turn could be characterized as a stable energy minimum. In addition, a clear chiral-effect destabilizing the β−II turn was apparent in the case of heterochiral (R,S) mimetics 5c
and 5e with respect to the homochiral (R,R) mimetics 5b and 5d and this energy-difference increased when the size of R group was increased from methyl to phenyl. In the latter case, a dramatic inversion in the stability of the γ-turn is also observed. Finally, models 5a and 5f bearing respectively achiral (i+2)
residues of Gly and Aib, displayed very similar relative stability patterns favoring the type β-II conformer over the γ-turns, albeit in the later case the energy-difference was lower in the latter case. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 energy values for the isomer pairs 5b-c and 5d-e are referred to the lower energy conformer in each case.
Figure 6 also depicts the Newman projections of models 5 with the β-lactam nitrogen atom and Cα' eclipsed. In homochiral (R,R) isomers the group R can adopt an alternative disposition only when the β-turn-II conformation is reached, leading to the more stable conformations. The exception to this general bias only occurs when the (i+2) residue is heterochiral with respect to the β-lactam (i+1) stereocenter and the size-difference between R and the β-lactam α-group is large. For instance, in model 5e with a (S)-phenylglycine (i+2) residue, conformer β-II is destabilized by the steric repulsion of the phenyl group and the β-lactam carbonyl oxygen atom, resulting in the stabilization of the γ-turn conformer.
Conclusions
The present work illustrates the intrinsic ability of short β-lactam peptide chains to form β-II and γ-turn structures in solution. It also emphasizes that "one carbon-scaffolded" β-lactam pseudopeptides provide very precise information on the H-bonding pattern in short peptide models, which complements prior quantum chemistry and gas-phase laser-desorbed experiments. In the light of the current results, it can be stated that chirality-driven conformational effect may ultimately determine the preferred type of turn stabilized by β-lactam pseudopeptides. Therefore, the β-LASD design model, consisting in the incorporation of an intra-residual methylene bridge to frozen type-II β-turns, must be applied cautiously to "all-L" peptide natural segments when chiral residues neighboring the central β-lactam core are involved. Despite this limitation, the β-LASD design method provides a simple steric model that opens up the route for a better understanding of the steric interactions driving the shallow β-/γ-transition in larger peptides. General Procedure for the Preparation of 1-Carboxyalkyl-3-methyl-3-(2-nitrobenzene sulfonylamino)azetidin-2-ones 8b-f: 18 To a solution of (R) methyl 2-methyl-serinate 10 (1.90 mmol, 0.32 g) and 2-nitrobenzenesulfonyl chloride (NsCl, 4.18 mmol, 0.935 g) in acetonitrile (30 mL) was added KHCO 3 (9.50 mmol, 0.951 g) and the suspension was stirred at reflux for 16 hours. Then, saturated aqueous NaHCO 3 (15 mL) was added and the mixture was extracted with EtOAc (3 x 15 mL).
The organic layer was dried (MgSO 4 ) and the solvents were evaporated at reduced pressure to give pure 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 acetonitrile (30 mL) was stirred at room temperature for 20 hours. Then saturated aqueous NaHCO 3 (15 mL) was added and mixture was extracted with EtOAc (3 x 15 mL), the organic fractions were dried (MgSO 4 ) and filtered, and solvents were evaporated in vacuo to give the corresponding β-azaalanine, which was purified by column chromatography (hexanes/EtOAc 4:1). To a stirred solution of the β-azaalanine (1 mmol) in dry THF (15 mL 4, 149.4, 136.4, 135.0, 133.7, 131.9, 125.9, 66.5, 54.8, 54.3, 20.5, 16.5 4, 146.4, 134.2, 132.2, 130.9, 129.1, 126.9, 126.5, 126.4, 123.1, 63.8, 58.4, 52.5, 17.8 
General Procedure for the Preparation of 3-Methyl-1-[(N-methylcarbamoyl)alkyl]-3-(2-
nitrobenzenesulfonylamino
(3R)-3-Methyl-1-[(1R)-1-(N-methylcarbamoyl)-ethyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-

2-one (12b):
The general procedure was followed from β-lactam (8b) (0.08 mmol, 0.030 g). The crude product was purified by preparative TLC (hexanes/EtOAc, 1:7 
(3R)-3-Methyl-1-[(1S)-1-(N-methylcarbamoyl)-ethyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-
2-one (12c):
The general procedure was followed from β-lactam (8c) (0.078 mmol, 0.028 g). The crude product was purified by preparative TLC (hexanes/EtOAc, 1:7 1, 167.2, 147.9, 135.4, 134.3, 133.7, 131.3, 129.6, 129.2, 125.9, 66.7, 60.1, 55.3, 27.0, 21.8 ; MS m/z (ESI, negative polarity): MS+1: 431.0; MS2(431.0): 193.7, 188.8, 137.8; MS3(188.8): 137.8, 131.8. Anal. calcd. for C 19 H 20 N 4 O 6 S: C, 52.77; H, 4.66; N, 12.96. Found: C, 52.91; H, 4.70; N, 12. 61.
(3R)-3-Methyl-1-[(1S)-1-(N-methylcarbamoyl)-1-phenyl-methyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-2-one (12e):
According to the aforementioned procedure (compound 12d) product 12e was prepared starting from β-lactam (8e) (0.31 mmol, 0.130 g) and methylamine (2M in THF; 0.465 mmol, 0.233 mL). An epimerization took place, and the mixture of diastereisomers 12e and 12d (ratio 96:4) was separated by preparative TLC (hexanes/EtOAc, 1:5). 7, 167.1, 147.5, 135.3, 133.9, 133.5, 132.9, 130.7, 129.2, 128.9, 128.4, 125.3, 65.9, 59.2, 54.8, 26.4, 21.3 
(3R)-3-Methyl-1-[1-(N-methylcarbamoyl)-isopropyl]-3-(2-nitrobenzenesulfonylamino)azetidin-2-one (12f):
The β-lactam (8f) (0.162 mmol, 0.160 g) was dissolved in CH 2 Cl 2 (2.5 mL) and cooled to 0 ºC. To this solution methylamine (2 M THF) (0.323 mmol, 0.162 mL) was added and then the reaction mixture was cooled to -12ºC (ice/NaCl) and EEDQ (0.072g, 0.292 mmol) was added as a CH 2 Cl 2 solution (2.5 mL). The reaction was slowly warmed to room temperature and stirred overnight. After this time, the reaction mixture was concentrated under reduced pressure and the crude product was purified by preparative TLC (hexanes/EtOAc, 1:7) to afford pure N-methylamide 12f as a white powder. 5, 168.3, 148.2, 135.4, 134.1, 132.6, 130.2, 124.8, 64.8, 60.2, 53.8, 25.8, 23.4, 23.3, 20 
General Procedure for the Preparation 3-Acetamido-3-methyl-1-[(N-methylcarbamoyl)-alkyl]-azetidin-2-ones (5a-f):
To a stirred solution of the corresponding β-lactam 12 (0.067 mmol, 0.045 g) in dry CH 3 CN (5 mL) thiophenol (0.335 mmol, 0.034 g) and K 2 CO 3 (0.268 mmol, 0.037 g) were added.
After stirring at room temperature for 1 h (monitoried by TLC and 1 H NMR) acetic anhydride (0.402 mmol, 0.088 g) was added and reaction was stirred overnight. The solvent was evaporated under reduced pressure and crude was purified by preparative TLC (hexanes/EtOAc, 1:7).
(R)-3-Acetamido-3-methyl-1-[1-(N-methylcarbamoyl)methyl]azetidin-2-one (5a):
The general procedure was followed from α-(2-nosyl)-β-lactam 12a (0.084 mmol, 0.030 g). 7, 168.8, 168.0, 65.0, 53.5, 45.3, 26.3, 22.9, 20.5 6, 168.6, 63.5, 50.2, 49.8, 26.5, 23.0, 20.7, 14.4 4, 170.5, 168.6, 63.4, 56.2, 53.5, 26.4, 23.0, 20.6, 16. 
(3R)-3-Acetamido-3-methyl-1-[1-(1R)-(N-methylcarbamoyl)phenylmethyl]azetidin-2-one (5d):
The general procedure was followed from α-(2-nosyl)-β-lactam 12d (0.108 mmol, 0.047 g). 9, 169.2, 168.3, 134.3, 129.0, 128.9, 128.4, 63.4, 59.4, 51.3, 26.6, 22.9, 20. 1, 168.9, 168.3, 134.6, 128.8, 128.7, 128.5, 76.6, 63.4, 62.3, 53.9, 26.5, 23.0, 20.4 . MS m/z (Ion Source Type: ESI, negative polarity): MS-1: 288.1; MS2(288.0): 245. 8, 230.8, 188.8, 171.8, 126.8; MS3(245.8): 126.8; MS4(126.8): 111.8, 58.3. Anal. calcd. for C 15 H 19 N 3 O 3 : C, 62.27; H, 6.62; N, 14.52. Found: C, 62.67; H, 6.70; N, 14.30 .
(3R)-3-Acetamido-3-methyl-1-[1-(N-methylcarbamoyl)isopropyl]azetidin-2-one (5f): The general procedure was followed from α-(2-nosyl)-β-lactam 12f (0.091 mmol, 0.035 g). The crude product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.018 g (82%); yellowish powder; m.p. 170.7, 168.3, 62.2, 60.3, 51.0, 26.6, 24.8, 24.3, 22.9, 20.7 8, 168.8, 166.1, 147.4, 134.9, 133.8, 133.2, 132.6, 130.9, 130.2, 128.9, 128.5, 128.2, 128.1, 125.3, 70.1, 67.0, 56.6, 50.5, 49.5, 40.3, 25.4, 24.7, 13.4 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 calcd. for C 30 H 32 N 4 O 8 S: C, 59.20; H, 5.30; N, 9.20. Found: C, 58.86; H, 5.64 ; N, 9.01. 9, 169.5, 166.5, 147.4, 133.6, 133.2, 133.1, 130.9, 130.0, 129.0, 128.5, 128.2, 128.1, 127.9, 125.3, 69.5, 67.2, 56.6, 53.8, 53.5, 40.6, 29.7, 24.9, 15. 8, MS: 562.8, 500.9, 472.9, 394.0, 359.9, 115.9. Anal. calcd. for C 30 H 32 N 4 O 8 S: C, 59.20; H, 5.30; N, 9.20. Found: C, 59.14; H, 5.55; N, 8.92 . 8, 167.8, 165.9, 147.5, 136.0, 134.8, 134.0, 133.4, 133.3, 132.5, 131.1, 130.1, 129.1, 128.9, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 125.5, 69.9, 67.2, 59.2, 55.9, 52.3, 40.3, 25.5, 24.9 C, 62.67; H, 5.11; N, 8.35. Found: C, 62.60; H, 4.95; N, 8.07 . 1H), 5.19 (d, 1H, J = 12.5 Hz), 5.15 (d, 1H, J = 12.5 Hz), 3.76 (d, 1H, J = 5.5 Hz), 3.52 (d, 1H, J = 5.5 Hz), 3.25 (dd, 2H, J = 11.9 Hz) 167.4, 166.7, 147.3, 135.6, 135.3, 133.6, 133.5, 133.0, 131.1, 129.9, 129.2, 129.1, 129.0, 128.7, 128.5, 128.2, 127.9, 125.4, 69.3, 67.5, 59.7, 57.1, 53.6, 41.1, 25.0, 24.5 H, 5.11; N, 8.35. Found C, 62.32; H, 5.06; N, 7.98 .
General Procedure for the Preparation of Boc-(β-Lactam)-Aa-Aib-OH Compounds 6b-e:
Thiophenol ( 2, 171.2, 171.0, 156.6, 135.6, 131.8, 129.4, 128.4, 81.0, 68.8, 59.5, 50.8, 39.1, 28.7, 26.9, 25.8, 13.9 C, 60.95; H, 7.21; N, 9.69. Found C, 61.33; H, 6.95 ; N, 9.60.
2-{2-[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-(S)-propanamido}-2-methylpropanoic acid (6c) :
The general procedure was followed from compound 13c (1 mmol, 0.608 g 8, 155.5, 134.6, 130.7, 128.4, 127.4, 79.9, 67.7, 58.4, 49.8, 38.1, 29.7, 27.7, 25.8, 24.8, 12.9 . HRMS (TOF CI) m/z: 433.2221; C 22 H 31 N 3 O 6 requires: 433.2216. 8, 169.7, 168.9, 155.4, 133.7, 133.6, 130.3, 128.7, 128.3, 127.8, 127.2, 79.8, 67.6, 58.6, 56.8, 48.5, 27.3, 25.4, 23.7 . Thiophenol (5 mmol, 0.469 mL) and K 2 CO 3 (4 mmol, 0.567 g) were added to a solution of (3R)-3-
2-{[(3R)
-
HPLC-MS, MeOH
0.461 g) in MeCN (5 mL). The suspension was stirred for 2 h at r.t., the solvent was evaporated in vacuo and the residue was purified by column chromatography (EtOAc, then MeOH) to afford (3R)-3- 166.9, 153.4, 135.3, 130.3, 128.4, 127.1, 65.8, 58.8, 52.6, 49.9, 39.1, 28.2, 23.7, 23.6 175.8, 174.5, 168.3, 154.7, 133.5, 130.8, 129.1, 128.2, 81.6, 66.4, 59.9, 57.9, 48.6, 39.5, 28.7, 25.9, 25.3, 24.4, 23.8 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 57.1 (48), 55.1(53 172.9, 155.3, 134.9, 130.3, 128.4, 127.1, 79.6, 65.9, 58.9, 53.5, 52.5, 49.8, 38.5, 28.3, 23.4, 18.3 The mixture was stirred during 16 h while allowing it to reach r.t. slowly. The solvent was evaporated at low pressure, the residue was redissolved in CH 2 Cl 2 and it was washed with 1M HCl (3 x 10 mL) and sat NaHCO 3 (3 x 10 mL). After evaporation of the organic solvent, the crude product was purified by 
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2-(2-{(3R)-Benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-yl}-2-methylpro panamido)-(2R)-propanamide (7a):
The general procedure was followed from methyl 2- 175.0, 173.6, 173.2, 166.8, 156.1, 133.1, 130.3, 128.7, 127.8, 80.9, 77.2, 65.8, 59.8, 49.6, 38.9, 28.3, 24.3, 23.6, 15.9, 16.5 175.0, 173.6, 173.0, 166.7, 155.9, 133.0, 130.3, 128.7, 127.8, 80.9, 75.8, 65.9, 59.8, 49.6, 47.6, 38.9, 28.3, 24.3, 23.6, 16.5 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
2-(2-{(3R)-
